Skip to content
healthcare.dev

Maxi Nicotine

NDC 0536-1338, nicotine polacrilex, lozenge, from Rugby Laboratories, Inc..

Product NDC
0536-1338
Status
Listed
Labeler
Rugby Laboratories, Inc.
Dosage form
LOZENGE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA209206
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0536-1338 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NICOTINE4 mg/1

Pharmacologic classes

Cholinergic Nicotinic Agonist [EPC]; Nicotine [CS]

Package NDCNDC-11Package
0536-1338-09005361338093 BOTTLE, PLASTIC in 1 BOX (0536-1338-09) / 24 LOZENGE in 1 BOTTLE, PLASTIC
0536-1338-350053613383524 LOZENGE in 1 BOTTLE, PLASTIC (0536-1338-35)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 00536133809

    GET /v1/drugs/nadac/00536133809
  • NADAC price for package 00536133835

    GET /v1/drugs/nadac/00536133835

Use it

Look up 0536-1338 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0536-1338 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0536-1338. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.